(IN BRIEF) The largest study to date on testicular germ cell tumours (TGCTs) has revealed a potential link between testicular cancer risk and rare genetic variants affecting cellular movement and structure. Conducted by The Institute of Cancer Research, London, the … Read the full press release
Posted in Business, Financial, Healthcare, Industrial, Investment, Management, News, Science, Technology, United Kingdom
Tagged cancer genetics, cell movement genes, Clare Turnbull, DNA mutations, European Urology Open Science, genetic risk, heritability in cancer, Movember Foundation, personalised medicine, rare genetic variants, testicular cancer, testicular germ cell tumours, TGCT, The Institute of Cancer Research, translational genomics, UK Biobank, whole-exome sequencing, Zeid Kuzbari
(IN BRIEF) CCRM Nordic is building a new ATMP production facility in GoCo Health Innovation City, Sweden, to support the development of next-generation gene, cell, and tissue-based therapies. AFRY will serve as engineering partner and project manager, leading the design, … Read the full press release
Posted in Business, Environment, Financial, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Sweden, Technology
Tagged advanced therapy medicinal products, AFRY, ATMP, biotechnology innovation, CCRM Nordic, cell therapy, engineering partner, Fredrik Wessberg, future-proof lab design, gene therapy, GMP compliance, GoCo Health Innovation City, Martin Öman, Mölndal, partnership, personalised medicine, pharmaceutical manufacturing, project management, sustainability, sustainable pharmaceutical production, Sweden healthcare strategy
(IN BRIEF) The NextGen project, funded by the EU’s Horizon Europe program with €7.6 million, has commenced in Utrecht, the Netherlands. Led by a 21-member consortium including the European Society of Cardiology, the project aims to personalize therapies for patients … Read the full press release
Posted in Artificial Intelligence (AI), France, Healthcare, Netherlands, Society, Technology
Tagged AI, artificial-intelligence, cardiovascular disease, cardiovascular diseases, cardiovascular health, CVDs, ESC, European Society of Cardiology, EU’s Horizon Europe, genetics, personalised medicine, Professor Panos Deloukas, Professor Pim van der Harst, Queen Mary University of London, The NextGen project, therapies, University Medical Center Utrecht
(IN BRIEF) IQ Biozoom, a medical technology startup, is developing non-invasive home diagnostics that allow people to measure the concentration of biochemical substances in liquid analytes like saliva, sweat, urine, or tears. Their technology integrates inkjet printing with advanced semiconductors, … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Poland, Small Business, Technology
Tagged biomarker, biosensor system, blood glucose, blood glucose meters, Diabetes, endocrine disorders, glucose, glucose monitoring, home diagnostics, home tests, IQ Biozoom, lactate levels, medical technology, medical technology startup, medtech, metabolic disorders, non-invasive home diagnostics, non-invasive home testing, personalised medicine, saliva analysis, sports medicine, startup, VC Link fund
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?